UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Effects of Salmon Calcitonin on Trabecular Microarchitecture as Determined by Magnetic Resonance Imaging: Results From the QUEST Study

Journal of bone and mineral research, 2005-09, Vol.20 (9), p.1548-1561

2005

Volltextzugriff (PDF)

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate

Bone (New York, N.Y.), 2007-07, Vol.41 (1), p.122-128

2007

Volltextzugriff (PDF)

A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density

Bone (New York, N.Y.), 2007-05, Vol.40 (5), p.1238-1243

2007

Volltextzugriff (PDF)

Zoledronic acid 5 mg IV produces more rapid reduction in bone resorption markers compared to weekly 70 mg oral alendronate in post-menopausal women with osteoporosis/osteopenia

Journal of clinical densitometry, 2007, Vol.10 (2), p.S221-S221

2007

Volltextzugriff (PDF)

Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density

Menopause (New York, N.Y.), 2011-08, Vol.18 (8), p.851

2011

Volltextzugriff (PDF)

Zoledronic acid 5mg IV produces more rapid reduction in bone resorption markers compared to weekly 70mg oral alendronate in post-menopausal women with osteoporosis/osteopenia

Journal of clinical densitometry, 2007-04, Vol.10 (2), p.S221

2007

Volltextzugriff (PDF)

Single infusion of zoledronic acid 5mg provides sustained benefits in bone mineral density and biomarkers at 12 months in postmenopausal women with low bone mineral density and prior alendronate therapy

Journal of clinical densitometry, 2007-04, Vol.10 (2), p.S220-S221

2007

Volltextzugriff (PDF)

Acute effects of calcitonin nasal spray on serum C-telopeptide of type 1 collagen (CTx) levels in elderly osteopenic women with increased bone turnover

Calcified tissue international, 2004-12, Vol.75 (6), p.477-481

2004

Volltextzugriff (PDF)

Single infusion of zoledronic acid 5 mg provides sustained benefits in bone mineral density and biomarkers at 12 months in postmenopausal women with low bone mineral density and prior alendronate therapy

Journal of clinical densitometry, 2007, Vol.10 (2), p.S220-S221

2007

Volltextzugriff (PDF)

Transdermal nitroglycerin and nitrate tolerance

Annals of internal medicine, 1987-02, Vol.106 (2), p.325

Kriegman, A G

1987

Volltextzugriff (PDF)

A Comparison of Once-Daily Atenolol and Metoprolol Using Office and Ambulatory Blood Pressure Monitoring

Journal of clinical pharmacology, 1993-05, Vol.33 (5), p.418-426

1993

Volltextzugriff (PDF)

Medical advice by celebrities

The New England journal of medicine, 1989-03, Vol.320 (11), p.742

Dixon, R E

1989

Volltextzugriff (PDF)

Proper Classification of Pindolol

Chest, 1982-05, Vol.81 (5), p.660-660

Kriegman, Audrey G.

1982

Volltextzugriff (PDF)

Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension

Archives of family medicine, 1996-01, Vol.5 (1), p.17-24

1996

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(13)
magazinearticle
(1)

Sprache

Englisch
(14)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of Salmon Calcitonin on Trabecular Microarchitecture as Determined by Magnetic Resonance Imaging: Results From the QUEST Study

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate

A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density

Zoledronic acid 5 mg IV produces more rapid reduction in bone resorption markers compared to weekly 70 mg oral alendronate in post-menopausal women with osteoporosis/osteopenia

Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone density

Zoledronic acid 5mg IV produces more rapid reduction in bone resorption markers compared to weekly 70mg oral alendronate in post-menopausal women with osteoporosis/osteopenia

Single infusion of zoledronic acid 5mg provides sustained benefits in bone mineral density and biomarkers at 12 months in postmenopausal women with low bone mineral density and prior alendronate therapy

Acute effects of calcitonin nasal spray on serum C-telopeptide of type 1 collagen (CTx) levels in elderly osteopenic women with increased bone turnover

Single infusion of zoledronic acid 5 mg provides sustained benefits in bone mineral density and biomarkers at 12 months in postmenopausal women with low bone mineral density and prior alendronate therapy

Transdermal nitroglycerin and nitrate tolerance

A Comparison of Once-Daily Atenolol and Metoprolol Using Office and Ambulatory Blood Pressure Monitoring

Medical advice by celebrities

Proper Classification of Pindolol

Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension

Suchergebnisse filtern